Skip to content

Fulgent Genetics, Inc. FLGT Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin38.7%-1.8pp40.6%-0.7pp41.2%+1.2pp40%+1.2pp38.8%+1.0pp
Operating margin-33.1%-4.8pp-28.2%-5.7pp-22.5%+1.5pp-24%+0.6pp-24.6%+1.5pp
Net margin-23%-4.3pp-18.8%-5.1pp-13.6%+3.2pp-16.8%-2.9pp-13.9%+1.1pp
Returns
Return on equity-6.8%-1.4pp-5.4%-1.6pp-3.8%+0.7pp-4.5%-0.9pp-3.6%+0.2pp
Return on invested capital-10.1%-1.6pp-8.5%-1.7pp-6.8%+0.1pp-6.9%-0.2pp-6.7%+0.2pp
Efficiency
Asset turnover0.3×0.0×0.3×0.0×0.3×0.0×0.2×0.0×0.2×0.0×
Liquidity
Current ratio5.3×-1.2×6.5×-0.5×+1.0×-0.3×6.3×+1.5×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$34.00-5.9%$36.13-1.3%$36.62+0.2%$36.560.0%$36.56-2.5%
Valuation
Market capitalization$552.11M-7.1%$812.07M+17.4%$691.76M+16.4%$594.26M+13.9%$521.63M-7.7%
Price / sales1.7×-0.3×2.5×+0.3×2.2×+0.2×+0.2×1.8×-0.2×
Price / book0.5×0.0×0.7×+0.1×0.6×+0.1×0.5×+0.1×0.5×0.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Fulgent Genetics, Inc.'s profit margins?
Fulgent Genetics, Inc. (FLGT) runs a 38.7% gross margin and a -33.1% operating margin, with a -23.0% net margin.
Where do Fulgent Genetics, Inc.'s ratios come from?
Every ratio is computed from Fulgent Genetics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.